Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.53K Sell
97
-6
-6% -$400 ﹤0.01% 1329
2026
Q1
$6.42K Buy
103
+29
+39% +$2.02K ﹤0.01% 1413
2025
Q4
$4.91K Buy
74
+26
+54% +$1.68K ﹤0.01% 1107
2025
Q3
$3.17K Buy
48
+21
+78% +$1.66K ﹤0.01% 1062
2025
Q2
$2.36K Buy
+27
New +$2.12K ﹤0.01% 1019

Other funds holding DXCM

Rossby Financial's DXCM Position: Q2 2026 in Review

Rossby Financial reduced its DexCom (DXCM) stake by 5.8% in Q2 2026, selling an estimated $400 and leaving 97 shares worth $6.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1329.

Rossby Financial first reported a position in DXCM in Q2 2025 and has held it in 5 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Rossby Financial held 97 shares of DexCom worth $6.53K as of Q2 2026.
  • Rossby Financial sold 6 DexCom shares in Q2 2026, an estimated $400.
  • DexCom made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1329 holding.
  • Rossby Financial first reported a position in DexCom in Q2 2025 and has held it in 5 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.